https://www.selleckchem.com/pr....oducts/durvalumab.ht
To describe the clinical profile, long-term follow-up and outcome of juvenile systemic scleroderma (JSSc) from a tertiary care referral hospital in North-West India. A review of case records was performed and children with JSSc (disease onset 14 years of age) were analysed. Diagnosis was based on the Paediatric Rheumatology European Society/American College of Rheumatology/European League against Rheumatism provisional classification criteria for JSSc. Forty patients (28 girls and 12 boys; FM ratio= 2.31) were diagnosed with JSSc
Like
Comment
Share
